![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-inks-immune-disorder-drug-licensing-deal-with-chinas-futuregen-2024-06-13/
https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-buy-landos-expand-pipeline-immunity-related-illnesses-2024-03-25/
https://www.globenewswire.com/news-release/2024/03/21/2850157/0/en/Landos-Biopharma-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2023-Results.html
https://ir.landosbiopharma.com/news-releases/news-release-details/landos-biopharma-present-new-data-immunometabolism-19th-annual
https://www.globenewswire.com//news-release/2024/01/08/2805383/0/en/Landos-Biopharma-to-Present-New-Data-on-Immunometabolism-at-the-19th-Annual-Congress-of-the-European-Crohn-s-and-Colitis-Organisation.html
https://www.globenewswire.com//news-release/2023/11/21/2784002/0/en/Landos-Biopharma-Publishes-Results-of-NX-13-Phase-1b-Study-in-Ulcerative-Colitis-in-Journal-of-Crohn-s-and-Colitis.html
https://www.globenewswire.com//news-release/2023/11/09/2777272/0/en/Landos-Biopharma-Provides-Company-Update-and-Reports-Third-Quarter-2023-Results.html
https://www.globenewswire.com//news-release/2023/10/23/2764658/0/en/Landos-Biopharma-to-Present-at-the-American-College-of-Gastroenterology-2023-Annual-Scientific-Meeting.html
https://www.globenewswire.com//news-release/2023/09/19/2745549/0/en/Landos-Biopharma-to-Present-New-Data-on-NX-13-from-Phase-1b-Trial-in-Ulcerative-Colitis-at-United-European-Gastroenterology-UEG-Week-2023-Congress.html